Lone Tree, CONCT03958565Now EnrollingIRB Ready

Carcinoma, Non-Small-Cell Lung Clinical Trial in Lone Tree, CO

Access cutting-edge carcinoma, non-small-cell lung treatment through this clinical trial at a research site in Lone Tree. Study-provided care at no cost to qualified participants.

Sponsored by University of Colorado, Denver

Quick Self-Assessment

See if you qualify for this Lone Tree location

Preparing your pre-screening questions…

Expert Care in Lone Tree

Access carcinoma, non-small-cell lung specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related carcinoma, non-small-cell lung treatment provided free

Apply for This Lone Tree Location

Check if you qualify for this carcinoma, non-small-cell lung clinical trial in Lone Tree, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lone Tree

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lone Tree site if eligible
  4. 4Begin participation

About This Carcinoma, Non-Small-Cell Lung Study in Lone Tree

The purpose of this study is to assess percentage reduction in the of urine NTX and serum CTX , in patients with NSCLC and bone metastases 1) with actionable driver oncogene on standard of care (SOC) TKI at 3 months post treatment and 2) without actionable mutations on standard of care therapy (chemotherapy/immunotherapy) treated with zoledronic acid or denosumab at the same time period.

Sponsor: University of Colorado, Denver

Who Can Participate

Inclusion Criteria

Provision to sign and date the consent form
Stated willingness to comply with all study procedures and be available for the duration of the study
Be a male or female aged 18-100 years
Pathologically confirmed non-small cell lung cancer
Molecular testing through a CLIA-validated NGS assay. This can be done using either tissue based samples or blood-based samples (ctDNA)
ECOG PS 0-2
Decision to be on a particular standard of care TKI or chemotherapy +/- immunotherapy (clinical decision that would occur prior to study enrollment)
Patients who will be treated with an osteoclast inhibitor must receive dental clearance prior to starting treatment
Bone metastases must be detected through radiographic imaging prior to enrollment on this study.

Exclusion Criteria

Actionable driver mutation NSCLC patient who has been on anti-bone resorptive therapy a. Excluded anti-bone resorptive therapy includes: zolendronic acid, pamidronate, alendronate, denosumab or any medication that acts as an osteoclast inhibitor
Have any condition or illness that, in the opinion of the investigator, would compromise participant safety or interfere with evaluation while on standard of care treatments for the NSCLC.
Patients with actionable driver mutation who received TKI in past or currently on TKI prior to screening
Bone metastases that have received prior radiotherapy unless unequivocal progression has occurred since radiation therapy

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lone Tree?

Yes, this clinical trial (NCT03958565) has an active research site in Lone Tree, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Carcinoma, Non-Small-Cell Lung Treatment Options in Lone Tree, CO

If you're searching for carcinoma, non-small-cell lung treatment options in Lone Tree, CO, this clinical trial (NCT03958565) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lone Tree research site is actively enrolling participants for this clinical trial. You'll receive care from experienced carcinoma, non-small-cell lung specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all carcinoma, non-small-cell lung clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Lone Tree, CO

See all leukemia clinical trials recruiting in Lone Tree — not just this study.

Browse Leukemia Trials in Lone Tree →

Browse More Trials by Condition

Leukemia TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Lone Tree?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lone Tree, CO